• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Virology. Loss of HIV-specific memory B-cells as a potential mechanism for the dysfunction of the humoral immune response against HIV.

Giuseppe

Emeritus
Loss of HIV-specific memory B-cells as a potential mechanism for the dysfunction of the humoral immune response against HIV. (Virology, abstract, edited)

27. Virology. 2010 Feb 5;397(1):7-13. Epub 2009 Dec 4.

Loss of HIV-specific memory B-cells as a potential mechanism for the dysfunction of the humoral immune response against HIV.

Bussmann BM, Reiche S, Bieniek B, Krznaric I, Ackermann F, Jassoy C. - Institute of Virology, Max B?rger Research Center, Universit?t Leipzig, 04103 Leipzig, Germany.

A central, yet unresolved issue in the pathogenesis of HIV disease is the mechanism of antibody perturbation. In this study, HIV-specific memory B-cells were quantified in groups of infected subjects and compared with memory responses to other antigens and antibody titers. HIV-specific memory B-cell responses were vigorous in individuals with CD4(+) T-cell counts >350/microl and weak or undetectable in subjects with CD4(+) T-cell numbers <200/microl. Memory B-cell loss was permanent, because antiretroviral therapy failed to restore HIV-specific memory responses while influenza- and tetanus toxoid-specific memory B-cells remained unaffected or recovered. Antibody titers to Gag strongly correlated with memory B-cell frequencies. In contrast, Env-specific antibodies were maintained in advanced disease despite low or undetectable levels of memory B-cells. These results provide a potential mechanism by which destruction of HIV-specific CD4(+) T-cells affects the humoral immune response against HIV and compromises the ability to maintain an effective antibody response.

Copyright 2009 Elsevier B.V. All rights reserved.

PMID: 19962720 [PubMed - indexed for MEDLINE]

Publication Types:

* Research Support, Non-U.S. Gov't

MeSH Terms:

* Anti-Retroviral Agents/therapeutic use
* Antibodies, Bacterial/blood
* Antibodies, Viral/blood
* B-Lymphocytes/immunology*
* CD4 Lymphocyte Count
* HIV/immunology*
* HIV Antibodies/blood
* HIV Infections/drug therapy
* HIV Infections/immunology*
* Humans
* Immunologic Memory*
* Influenza, Human/immunology
* Tetanus Toxoid/immunology
* env Gene Products, Human Immunodeficiency Virus/immunology
* gag Gene Products, Human Immunodeficiency Virus/immunology

Substances:

* Anti-Retroviral Agents
* Antibodies, Bacterial
* Antibodies, Viral
* HIV Antibodies
* Tetanus Toxoid
* env Gene Products, Human Immunodeficiency Virus
* gag Gene Products, Human Immunodeficiency Virus

-
------
 
Back
Top Bottom